Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and WalesResearch Article Published on 2021-05-172022-10-28 Journal: BMC Medicine [Category] COVID-19, SARS, [키워드] 95% CI acute exacerbation acute exacerbation of chronic obstructive pulmonary disease Admission Analysis average changed changes in chronic obstructive COPD country COVID-19 COVID-19 lockdown COVID-19 pandemic death deaths estimate healthcare Hospital admission hypothesised Impact incidence incidence rate increase in linkage lockdown lockdown restriction Meta-analysis Mortality National outcomes primary care Public pulmonary disease recorded reduced reduction in reductions in respiratory infections Result resulting Self-management statistically significant substantial reduction supplementary material Transmission [DOI] 10.1186/s12916-021-02000-w PMC 바로가기 [Article Type] Research Article
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data이스라엘의 전국적인 예방접종 캠페인에 따른 SARS-CoV-2 감염 및 COVID-19 사례, 입원 및 사망에 대한 mRNA BNT162b2 백신의 영향 및 효과: 국가 감시 데이터를 사용한 관찰 연구Observational Study Published on 2021-05-152022-09-11 Journal: Lancet (London, England) [Category] Fulltext, SARS, 변종, 임상, [키워드] 95% CI adjusted age all age group all age groups Analysis Asymptomatic asymptomatic infection authorisation B.1.1.7 B.1.1.7 SARS-CoV-2 variant B.1.1.7 variant BNT162b2 calculated caused Coverage COVID-19 COVID-19 cases COVID-19 vaccination COVID-19 vaccine COVID-19-related death Critical death Decline declined defined dose effective Effectiveness Emergency use estimate evaluate help hospitalisation hospitalisations Impact incidence incidence rate incidence rates individual International laboratory-confirmed SARS-CoV-2 infection Ministry of Health MoH mRNA mRNA BNT162b2 vaccine National non-proprietary name of BNT162b2 Older outcome outcomes pandemic PCR test Pfizer-BioNTech Prevalence prevelance proportion receiving Regression model SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2-positive specimen second dose second dose of vaccine severe disease Sex spike gene surveillance data sustained symptomatic symptomatic and asymptomatic symptomatic COVID-19 symptomatic infection tested the vaccine vaccinated individual vaccinated individuals vaccination Vaccine was used widespread [DOI] 10.1016/S0140-6736(21)00947-8 PMC 바로가기 [Article Type] Observational Study
Epidemiological Aspects of the Initial Evolution of COVID-19 in Microregion of Uberlândia, Minas Gerais (MG), BrazilArticle Published on 2021-05-142022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, SARS, [키워드] Affect affected Analysis applied aspect Brazil Care Characteristics Comorbidity conducted confirmed case contributed COVID-19 cross-sectional death determine diabete diagnosed with COVID-19 died Epidemiologic studies epidemiological global public health hospital implementation incidence incidence rate Multimorbidity progression required risk risk factor SARS-CoV-2 SARS-CoV-2 virus the disease Variation virus World Health Organization [DOI] 10.3390/ijerph18105245 PMC 바로가기 [Article Type] Article
The lower respiratory tract microbiome of critically ill patients with COVID-19Article Published on 2021-05-122022-10-04 Journal: Scientific Reports [Category] SARS, 바이오마커, 치료법, [키워드] 16S rRNA Acinetobacter antibiotic Bacterial bacterial microbiome bacterial superinfection BAL Bronchoalveolar lavage characterized clinical microbiology Clinical outcome Clostridium collected commensal bacteria COVID-19 COVID-19 infection COVID-19 pandemic Critically ill Critically ill patient critically ill patients Enterobacteriaceae Haemophilus influenzae incidence rate Infection Lower respiratory tract lung Microbiome multidrug resistant Non-COVID-19 Pathogens Patient patients patients with pneumonia performed Pneumonia Pseudomona SARS-COV-2 infection secondary bacterial infection significant increase Streptococcus subject with COVID-19 [DOI] 10.1038/s41598-021-89516-6 PMC 바로가기 [Article Type] Article
Mutation in a SARS-CoV-2 Haplotype from Sub-Antarctic Chile Reveals New Insights into the Spike’s DynamicsArticle Published on 2021-05-112022-10-28 Journal: Viruses [Category] COVID-19, SARS, [키워드] 501Y.V1 501Y.V2 accompanied B.1.1.28.1 B.1.1.7 B.1.351 Comparative continuous surveillance COVID19 D614G domain Dynamics Haplotype higher infectivity highest incidence rate indicated insight Lineage lineages molecular molecular analysis molecular mechanism mutant Mutation New nine Occurrence P.1 Receptor binding domain Region replaced resulting SARS-CoV-2 SARS-CoV-2 strains SARS-CoV-2 variants SARS-CoV2 significant increase Spike protein strain synergistic variant Variation virulence [DOI] 10.3390/v13050883 PMC 바로가기 [Article Type] Article
Delay-Adjusted Age-Specific COVID-19 Case Fatality Rates in a High Testing Setting: South Korea, February 2020 to February 2021Article Published on 2021-05-112022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, SARS, [키워드] affected age-specific death rate applied Case fatality rate CFR coronavirus disease country COVID-19 COVID-19 case COVID-19 cases cumulative cumulative mortality death death rate deaths disease onset fatality highest incidence rate individual Older Prevent Rate recorded Republic of Korea resulting risk SARS-CoV-2 South Korea statistical survival Testing [DOI] 10.3390/ijerph18105053 PMC 바로가기 [Article Type] Article
Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection무증상 SARS-CoV-2 감염 환자의 바이러스 역학 및 항체 반응Article Published on 2021-05-102022-09-12 Journal: Signal Transduction and Targeted Therapy [Category] Fulltext, SARS, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Antibody Response Antibody responses Asymptomatic asymptomatic individual Asymptomatic individuals asymptomatic infection coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 pandemic COVID-19 patient Critical doubt Effective vaccines Efficacy eight immune response immune responses immunology incidence rate individual Microbiology over peaked Policy Re-infection Recovered COVID-19 patients reported Safe SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome Coronavirus short-lived viral copy number viral dynamics Wuhan [DOI] 10.1038/s41392-021-00596-2 PMC 바로가기 [Article Type] Article
Association of serum uric acid levels with COVID-19 severityResearch Published on 2021-05-082022-10-28 Journal: BMC Endocrine Disorders [Category] COVID-19, SARS, [키워드] accompanied Admission age Analysis association BMI contrary controls COVID-19 COVID-19 case COVID-19 patient COVID-19 patients defined discharge disease examined female patient Follow-up guideline healthy control healthy controls higher risk incidence rate independent risk factor male Male sex moderate Multiple linear regression negative correlation no significant difference partial correlation Patient patients patients with COVID-19 Result risk SARS-COV-2 infection serum severe group severe symptom severity severity of COVID-19 Sex significantly higher stratified subjects supplementary material the healthy uric acid Uric acid/creatinine ratio with COVID-19 [DOI] 10.1186/s12902-021-00745-2 PMC 바로가기 [Article Type] Research
The ongoing indirect effect of the COVID-19 pandemic on a pediatric emergency departmentResearch Article Published on 2021-05-062022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, SARS, [키워드] 95%CI Adults Care center children COVID-19 pandemic decrease Health highlight Hospitalization incidence rate Jerusalem lifted lockdown moderate morbidity and mortality pandemic parent pediatric performed potential risk raise Ratio remained reported Result resulting returned risk SARS-CoV-2 coronavirus Severe case severity These data Variation were recorded [DOI] 10.1371/journal.pone.0251003 PMC 바로가기 [Article Type] Research Article
Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysisCOVID-19 및 중증 저산소증(COVID STEROID 2) 환자에서 덱사메타손의 고용량 및 저용량 시험: 이차 베이지안 분석을 위한 프로토콜Comparative Study Published on 2021-05-012022-09-11 Journal: Acta Anaesthesiologica Scandinavica [Category] SARS, 임상, [키워드] adjusted analysed Analysis Bayesian analysis binary outcome clinically Clinicians conducted coronavirus disease Coronavirus disease 2019 Corticosteroids COVID COVID-19 credibility interval Critically ill Critically ill patient days alive death decrease Dexamethasone Effect help hypoxia hypoxic respiratory failure incidence rate Interpretation intravenously logistic regression model logistic regression models Lower lower dose mean difference Mortality optimal dose outcome patients with COVID-19 Primary outcome Probability protocol randomised Registered researcher Respiratory failure risk secondary outcome Sensitivity analyses sensitivity analysis severe hypoxia statistical steroid Stratification Support the mean Trial variable with COVID-19 [DOI] 10.1111/aas.13793 PMC 바로가기 [Article Type] Comparative Study